Cargando…

Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade

Detalles Bibliográficos
Autores principales: Casadevall, David, Li, Xiaotong, Powles, Ryan L., Wali, Vikram B., Buza, Natalia, Pelekanou, Vasiliki, Dhawan, Arjun, Foldi, Julia, Szekely, Borbala, Lopez-Giraldez, Francesc, Hatzis, Christos, Pusztai, Lajos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450962/
https://www.ncbi.nlm.nih.gov/pubmed/32914041
http://dx.doi.org/10.1200/PO.18.00335
_version_ 1783574895259549696
author Casadevall, David
Li, Xiaotong
Powles, Ryan L.
Wali, Vikram B.
Buza, Natalia
Pelekanou, Vasiliki
Dhawan, Arjun
Foldi, Julia
Szekely, Borbala
Lopez-Giraldez, Francesc
Hatzis, Christos
Pusztai, Lajos
author_facet Casadevall, David
Li, Xiaotong
Powles, Ryan L.
Wali, Vikram B.
Buza, Natalia
Pelekanou, Vasiliki
Dhawan, Arjun
Foldi, Julia
Szekely, Borbala
Lopez-Giraldez, Francesc
Hatzis, Christos
Pusztai, Lajos
author_sort Casadevall, David
collection PubMed
description
format Online
Article
Text
id pubmed-7450962
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-74509622020-09-09 Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade Casadevall, David Li, Xiaotong Powles, Ryan L. Wali, Vikram B. Buza, Natalia Pelekanou, Vasiliki Dhawan, Arjun Foldi, Julia Szekely, Borbala Lopez-Giraldez, Francesc Hatzis, Christos Pusztai, Lajos JCO Precis Oncol Case Report American Society of Clinical Oncology 2019-05-10 /pmc/articles/PMC7450962/ /pubmed/32914041 http://dx.doi.org/10.1200/PO.18.00335 Text en © 2019 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/
spellingShingle Case Report
Casadevall, David
Li, Xiaotong
Powles, Ryan L.
Wali, Vikram B.
Buza, Natalia
Pelekanou, Vasiliki
Dhawan, Arjun
Foldi, Julia
Szekely, Borbala
Lopez-Giraldez, Francesc
Hatzis, Christos
Pusztai, Lajos
Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
title Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
title_full Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
title_fullStr Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
title_full_unstemmed Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
title_short Genomic and Immune Profiling of a Patient With Triple-Negative Breast Cancer That Progressed During Neoadjuvant Chemotherapy Plus PD-L1 Blockade
title_sort genomic and immune profiling of a patient with triple-negative breast cancer that progressed during neoadjuvant chemotherapy plus pd-l1 blockade
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450962/
https://www.ncbi.nlm.nih.gov/pubmed/32914041
http://dx.doi.org/10.1200/PO.18.00335
work_keys_str_mv AT casadevalldavid genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT lixiaotong genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT powlesryanl genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT walivikramb genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT buzanatalia genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT pelekanouvasiliki genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT dhawanarjun genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT foldijulia genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT szekelyborbala genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT lopezgiraldezfrancesc genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT hatzischristos genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade
AT pusztailajos genomicandimmuneprofilingofapatientwithtriplenegativebreastcancerthatprogressedduringneoadjuvantchemotherapypluspdl1blockade